Artera


Artera is a leading precision medicine company developing AI tests to personalize cancer therapy. Their mission is to enable personalized cancer treatment and shared decision-making between clinicians and patients, leveraging advanced AI technology to improve treatment accuracy and outcomes.

Industries

Artificial Intelligence
Artificial Intelligence (AI)
Biotechnology
Health Care
Health Diagnostics
Life Science
Medical
Medical Device
Precision Medicine
Hospitals and Health Care

Nr. of Employees

medium (51-250)

Artera

Los Altos, California, United States


Products

AI-enabled multimodal biomarker test for localized prostate cancer (prostate biopsy assay)

A multimodal AI assay that evaluates digitized biopsy images and clinical variables to produce individualized predictive and prognostic results to support treatment decisions for localized prostate cancer; provided as a laboratory-developed test.

Natural Gas Distribution and Pipeline Construction Services

Turn-key design and construction services for natural gas distribution and transmission pipelines, combining engineering resources with construction expertise.

Natural Gas Distribution Services

Installation, maintenance, repair and replacement of distribution and regional transmission systems of natural gas provided by Southeast Connections.

Miller Pipeline

Provider of integrated essential and critical infrastructure services including natural gas distribution, pipeline construction, maintenance, and replacement.

Hydro-X

Integrated essential and critical infrastructure services provided by Artera.

Utility Horizontal Directional Drilling

Horizontal directional drilling (HDD) services for underground utility and pipeline construction.

View All Products

Services

Provision of a clinically available laboratory-developed diagnostic test that analyzes digitized biopsy slides and clinical data to generate predictive and prognostic reports for localized prostate cancer. Testing performed in a CLIA-certified laboratory; ordering limited to clinicians.

Registry trial design and execution to collect real-world outcomes and measure clinical impact of the diagnostic test in practice.

Expertise Areas

  • AI-driven biomarker development
  • Digital histopathology and image analytics
  • Clinical validation and use of Phase 3 trial datasets
  • Clinical laboratory testing (CLIA LDT workflows)
  • Show More (4)

Key Technologies

  • Multimodal deep learning
  • Digital slide scanning and image preprocessing
  • Cloud-based analytics (region-aware deployments)
  • AES-256 encryption
  • Show More (4)

News & Updates

Chicago, IL. Embrace new connections with colleagues from around the world, immerse yourself in cutting-edge scientific discoveries, and add your voice to conversations that will transform tomorrow’s outcomes.

ArteraAI has received Medicare reimbursement approval for its prostate cancer test, supporting broader access and affordability.

Artera’s MMAI platform has been recognized among TIME’s 2024 Best Inventions for its innovative approach to cancer prognosis and therapy personalization.

Recognition of Artera’s MMAI platform among TIME’s 2024 Best Inventions for its innovation in cancer prognosis and personalized therapy.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.